Tocilizumab: le point sur un nouveau médicamentMOULIS, Guillaume; SAILLER, Laurent; MONTASTRUC, Jean-Louis et al.MT. Médecine thérapeutique. 2011, Vol 17, Num 1, pp 23-33, issn 1264-6520, 11 p.Article

Tocilizumab: is there life beyond anti-TNF blockade?ALVES, J. D; MARINHO, A; SERRA, M. J et al.International journal of clinical practice (Esher). 2011, Vol 65, Num 4, pp 508-513, issn 1368-5031, 6 p.Article

Onset of psoriasis following treatment with tocilizumabLAURENT, S; LE PARC, J.-M; CLERICI, T et al.British journal of dermatology (1951). 2010, Vol 163, Num 6, pp 1364-1365, issn 0007-0963, 2 p.Article

Refractory neuro-Behçet treated by tocilizumab: a case reportURBANIAK, P; HASLER, P; KRETZSCHMAR, S et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 3, issn 0392-856X, S73-S75, SUP72Article

Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteriaIKING-KONERT, Christof; ARINGER, Martin; WOLLENHAUPT, Jurgen et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 11, pp 1986-1990, issn 0003-4967, 5 p.Article

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumabOGATA, Atsushi; MORISHIMA, Atsuyoshi; HIRANO, Toru et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 1164-1165, issn 0003-4967, 2 p.Article

Interstitial Granulomatous Dermatitis With Arthritis Responding to TocilizumabSCHANZ, Stefan; SCHMALZING, Marc; GUENOVA, Emmanuella et al.Archives of dermatology (1960). 2012, Vol 148, Num 1, pp 17-20, issn 0003-987X, 4 p.Article

In Vivo Effects of the Anti―Interleukin-6 Receptor Inhibitor Tocilizumab on the B Cell CompartmentROLL, Petra; MUHAMMAD, Khalid; SCHUMANN, Mathias et al.Arthritis and rheumatism. 2011, Vol 63, Num 5, pp 1255-1264, issn 0004-3591, 10 p.Article

Effet à court terme de l'inhibition de l'IL-6 dans la spondylarthriteWENDLING, Daniel; BOSSERT, Marie; PRATI, Clément et al.Revue du rhumatisme (Ed. française). 2011, Vol 78, Num 2, issn 1169-8330, p. 193Article

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine familyMIHARA, Masahiko; KASUTANI, Keiko; OKAZAKI, Makoto et al.International immunopharmacology. 2005, Vol 5, Num 12, pp 1731-1740, issn 1567-5769, 10 p.Article

Infection à Bartonella Henselae au cours d'un traitement par tocilizumabMILIN, Morgane; ACQUITTER, Marie; LE BERRE, Rozenn et al.Revue du rhumatisme (Ed. française). 2013, Vol 80, Num 2, pp 184-185, issn 1169-8330, 2 p.Article

Tocilizumab for multirefractory adult-onset Still's diseaseDE BANDT, M; SAINT-MARCOUX, B.Annals of the rheumatic diseases. 2009, Vol 68, Num 1, pp 155-156, issn 0003-4967, 2 p.Article

Therapeutic effect of tocilizumab on two patients with polymyositisNARAZAKI, Masashi; HAGIHARA, Keisuke; SHIMA, Yoshihito et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 7, pp 1344-1346, issn 1462-0324, 3 p.Article

Tocilizumab in Refractory Adult Still's DiseasePUECHAL, Xavier; DE BANDT, Michel; SCHAEVERBEKE, Thierry et al.Arthritis care and research. 2011, Vol 63, Num 1, pp 155-159, issn 0893-7524, 5 p.Article

Ulcérations buccales aphtoïdes persistantes associées au tocilizumab: deux cas = Persistent aphthous mouth ulcers associated with tocilizumab: Two casesSAMIMI, M; LAUFERON, F; HÜTTENBERGER, B et al.Annales de dermatologie et de vénéréologie. 2013, Vol 140, Num 2, pp 120-124, issn 0151-9638, 5 p.Article

Interleukin-6-producing dermoid cyst associated with multicentric Castleman's diseaseEBARA, Shigeyuki; SONG, Soken-Nakazawa J; MIZUTA, Hiroyuki et al.International journal of hematology. 2012, Vol 95, Num 2, pp 198-203, issn 0925-5710, 6 p.Article

Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralizationIGAWA, Tomoyuki; ISHII, Shinya; WAKABAYASHI, Tetsuya et al.Nature biotechnology (Print). 2010, Vol 28, Num 11, pp 1203-1207, issn 1087-0156, 5 p.Article

Trouble du cycle capillaire sous tocilizumabVIDON, Claire; BOSSERT, Marie; LOHSE-WALLISER, Anne et al.Revue du rhumatisme (Ed. française). 2014, Vol 81, Num 2, issn 1169-8330, p. 192Article

Rhumatologie pédiatrique: Les arthrites juvéniles idiopathiques : ACR 2011: Des Etudes marquantes en avant-premièreBADER-MEUNIER, Brigitte.Rhumatos. 2011, Vol 8, Num 73, pp 401-402, issn 1771-0081, 2 p.Article

Réponse prolongée après traitement par tocilizumab d'une polychondrite atrophiante = Sustained response with tocilizumab in a case of refractory relapsing polychondritisWEBER, E; GAULTIER, J.-B; PAUL, S et al.La Revue de médecine interne (Paris). 2014, Vol 35, Num 3, pp 196-198, issn 0248-8663, 3 p.Article

Le polynucléaire neutrophile dans la polyarthrite rhumatoïde: une cellule oubliée ? = Neutrophils in rheumatoid arthritis: a forgotten cell?CONTIS, A; KOSTINE, M; RICHEZ, C et al.La Lettre du rhumatologue. 2014, Num 407, pp 12-15, issn 0761-5027, 4 p.Article

Thérapeutique des spondylarthrites: A l'ouest, rien de nouveau ?WENDLING, Daniel.Rhumatos. 2012, Vol 9, Num 79, pp 210-211, issn 1771-0081, 2 p.Article

Sustained Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Patients with Rheumatoid ArthritisAGUILAR-LOZANO, Luis; JOSE DIONISIO CASTILLO-ORTIZ; VARGAS-SERAFIN, Cesar et al.Journal of rheumatology. 2013, Vol 40, Num 7, pp 1069-1073, issn 0315-162X, 5 p.Article

Risk of infections in rheumatoid arthritis patients treated with tocilizumabLANG, Veronika R; ENGLBRECHT, Matthias; ZWERINA, Jochen et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 5, pp 852-857, issn 1462-0324, 6 p.Article

Tocilizumab for the Treatment of Juvenile Idiopathic ArthritisDECELLE, Kendra; HORTON, Evan R.The Annals of pharmacotherapy. 2012, Vol 46, Num 6, pp 822-829, issn 1060-0280, 8 p.Article